Real‐World Outcomes of Baricitinib and Ritlecitinib in Refractory Alopecia Areata: Response Predictors and Relapse After Discontinuation or Dose Reduction

Rina Hayashi, Saori Takamura, Tomoo Fukuda

Open source

DOI
10.1111/1346-8138.70241
Published
2026-03-31
Container
The Journal of Dermatology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/1346-8138.70241,
  title = {Real‐World Outcomes of Baricitinib and Ritlecitinib in Refractory Alopecia Areata: Response Predictors and Relapse After Discontinuation or Dose Reduction},
  author = {Rina Hayashi and Saori Takamura and Tomoo Fukuda},
  year = {2026},
  journal = {The Journal of Dermatology},
  doi = {10.1111/1346-8138.70241},
  url = {https://doi.org/10.1111/1346-8138.70241}
}

RIS

TY  - JOUR
TI  - Real‐World Outcomes of Baricitinib and Ritlecitinib in Refractory Alopecia Areata: Response Predictors and Relapse After Discontinuation or Dose Reduction
AU  - Rina Hayashi
AU  - Saori Takamura
AU  - Tomoo Fukuda
PY  - 2026
JO  - The Journal of Dermatology
DO  - 10.1111/1346-8138.70241
UR  - https://doi.org/10.1111/1346-8138.70241
ER  - 

APA

Hayashi, R., Takamura, S., & Fukuda, T. (2026). Real‐World Outcomes of Baricitinib and Ritlecitinib in Refractory Alopecia Areata: Response Predictors and Relapse After Discontinuation or Dose Reduction. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.70241

Source records